Imatinib failed to eradicate chronic myeloid leukemia in a patient with minimal residual disease

MeSH terms

• Adult
• Antineoplastic Agents / therapeutic use*
• Benzamides
• Drug Administration Schedule
• Humans
• Imatinib Mesylate
• Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
• Male
• Neoplasm, Residual / drug therapy*
• Piperazines / administration & dosage
• Piperazines / therapeutic use*
• Pyrimidines / administration & dosage
• Pyrimidines / therapeutic use*
• Remission Induction
• Treatment Failure
• Treatment Outcome